ATRA News

Pomerantz LLP Announces Commencement of Class Action Against Atara Biotherapeutics, Inc. – ATRA

ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit

Pomerantz LLP Announces Commencement of Class Action Litigation Against Atara Biotherapeutics, Inc. – ATRA

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATRA

Pomerantz LLP Announces Class Action Litigation Filing Against Atara Biotherapeutics, Inc. – ATRA

ATRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Pomerantz LLP Announces Commencement of Class Action Lawsuit Against Atara Biotherapeutics, Inc. – ATRA

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATRA

Pomerantz LLP Announces Class Action Litigation Against Atara Biotherapeutics, Inc. – ATRA

ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026